GlassScriptPhysician profile
Judith L Genova
NPI 1477616498
$2,180.20
in general payments reported to CMS, 2019-2025
15 companies · $756 in 2025
The $756 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $537 · 2024: $887 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,180.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $974.30 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $158.71 | 2024 | Austedo Xr |
| Janssen Pharmaceuticals, INC | $157.24 | 2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $124.09 | 2025 | Breztri |
| Ani Pharmaceuticals, INC. | $123.99 | 2023 | Purified Cortrophin Gel |
| Ferring Pharmaceuticals INC. | $123.58 | 2023 | Rebyota |
| Neurocrine Biosciences, INC. | $123.35 | 2024 | Ingrezza |
| Gilead Sciences, INC. | $120.07 | 2025 | Epclusa |
| Phathom Pharmaceuticals, INC. | $115.10 | 2024 | Voquezna |
| Amgen INC. | $73.44 | 2025 | Uplizna |
| Biogen, INC. | $25.12 | 2023 | Avonex, Vumerity |
| Axsome Therapeutics, INC. | $16.97 | 2024 | Auvelity |
| Integra Lifesciences Corporation | $15.73 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Solventum Corporation | $15.38 | 2024 | Prevena, V.A.C. Veraflo |
| Paratek Pharmaceuticals, INC. | $13.13 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Genova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.